Pulmonary infection in cystic fibrosis.
D000293:Adolescent; D000328:Adult; D000464:Alginates / Q000096:biosynthesis; D001228:Aspergillosis / Q000150:complications; D001232:Aspergillus fumigatus; D001424:Bacterial Infections / Q000150:complications / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications*; D005260:Female; D006192:Haemophilus Infections / Q000150:complications / Q000382:microbiology; D006193:Haemophilus influenzae; D006801:Humans; D007223:Infant; D007875:Legionella; D008172:Lung Diseases, Fungal / Q000150:complications; D008297:Male; D009164:Mycobacterium Infections / Q000150:complications / Q000382:microbiology; D026741:Physical Therapy Modalities; D011552:Pseudomonas Infections / Q000150:complications / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000378:metabolism; D012141:Respiratory Tract Infections / Q000150:complications* / Q000382:microbiology; D013183:Sputum / Q000382:microbiology; D013203:Staphylococcal Infections / Q000150:complications / Q000382:microbiology; D014777:Virus Diseases / Q000150:complications / Q000382:microbiology
D000464:Alginates